Skip to content
Screener

Guardant Health GH Q2 2025 earnings

Reported July 30, 2025 · After market close

Revenue$232.1MMiss by $3.6M
EPS-$0.44Beat by $0.08
Revenue estimate$235.7M
EPS estimate-$0.52

Next report

Oct 28, 2026 (in 2 months)
Revenue estimate$350.1M
EPS estimate-$0.28

Financials

Q2 2025

Income statement

See full
Revenue$232.1M+30.9%
Gross profit$150.9M+44.0%
Operating income-$106.4M-5.8%
Net income-$99.9M+2.7%
EPS (diluted)-$0.80+4.8%

Balance sheet

See full
Cash & equivalents$735.5M-29.0%
Total debt$1.3B+568%
Total equity-$305.5M-18,838%
Total assets$1.3B-17.2%

Cash flow

See full
Operating cash flow-$60.3M+35.9%
CapEx$5.6M+11.3%
Free cash flow-$65.9M+33.5%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$6.19B+75.2%
Enterprise value$6.79B+152%
P/S7.5×+2.0×

Profitability

See full
Gross margin62.8%+4.4pp
Operating margin-55.6%-12.8pp
Net margin-49.9%-12.8pp
FCF margin-32.8%-7.5pp

Returns & leverage

See full
Current ratio3.7×-2.7×

Segments

By product

See full
Oncology$158.7M+21.8%
Biopharma and data$56.0M+27.5%
Screening$14.8M—
Licensing and other$2.6M-15.3%

By segment

See full
Reportable Segment$232.1M+30.9%

FAQ

When did Guardant Health report Q2 2025 earnings?
Guardant Health (GH) reported Q2 2025 earnings on July 30, 2025 after market close.
What were Guardant Health's Q2 2025 revenue and EPS?
Guardant Health reported revenue of $232.1M and eps of $-0.44 for Q2 2025.
Did Guardant Health beat estimates in Q2 2025?
Revenue missed the consensus estimate of $235.7M by $3.6M. EPS beat the consensus estimate of $-0.52 by $0.08.
How did Guardant Health's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 30.9% from $177.2M a year earlier and eps grew 8.3% from $-0.48.
Where can I find Guardant Health's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001576280-25-000245) and the 10-Q periodic report (0001576280-25-000246) directly on SEC EDGAR. The filing index links above go to sec.gov.